HAVN Life Sciences Inc.
HAVN Life Sciences Inc.
HAVN Life Sciences Inc. is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs and the development of natural health products and innovative therapies to support brain health. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, the company offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.
HAVN Life Sciences Inc. (HAVN)
SEDAR Information
Company Info
Capitalization
News Releases
Bulletins
2022-0801 – Consolidation - HAVN Life Sciences Inc. (HAVN)
Le 2 août/August 2022
HAVN Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,109,665 common shares.
The name and symbol will not change.
CSE Filings
Advertisement
Publicité
Upcoming Events
Arcview Access Cannabis Investment Summit
